Quarterly Financial Results for the 1st Quarter, Ended June 30, 2022 (Japanese GAAP, Consolidated)

Name of Listed Company: Kaneka Corporation

URL https://www.kaneka.co.jp/en/

Title: Executive Officer - Investors & Public Relations Department

Scheduled date for submitting financial statements: August 12, 2022

Scheduled date of dividend distribution: －

Note: Figures have been rounded down to the nearest million yen.

1. Consolidated Business Performance for the 1st Quarter, Ended June 30, 2022 (from April 1, 2022 to June 30, 2022)

Note: Comprehensive income: ¥17,664 million (108.6%) for the three months ended June 30, 2022

¥8,466 million (145.5%) for the three months ended June 30, 2021

Note: Year-on-year changes in ordinary income and net income attributable to owners of parent in the first quarter ended June 30, 2021 are presented as "-," since they exceed 1,000%.

Reference: Shareholders' equity: ¥400,332 million as of June 30, 2022 ¥387,150 million as of March 31, 2022

Note: Changes in dividend forecast during the quarter under review: No

3. Forecast for Consolidated Business Performance for the Year Ended March 31, 2023 (from April 1, 2022 to March 31, 2023)

(Percentage figures represent changes from the corresponding periods of the previous fiscal year)

Note: Revisions to consolidated business performance forecasts during the quarter under review: No

Note: For details, please refer to the section entitled "(3) Notes to the Consolidated Financial Statements (Changes in Accounting Principles) " under "2. Quarterly Consolidated Financial Statements and Main Notes" on page 9.

(4) Number of shares outstanding (common stock)

※ These financial statements are exempt from audit procedures

※ Explanations or other items pertaining to appropriate use of business performance forecasts The business performance forecasts and certain other statements contained in this document are forward-looking statements, which are based on information currently available to the Company and certain assumptions determined to be reasonable by the Company. For a variety of reasons, actual performance may differ substantially from these forecasts. They do not constitute a guarantee that the Company will achieve these forecasts or other forward-looking statements. For cautionary items used in business performance forecasts, please refer to the section entitled "(3) Consolidated Business Forecasts" under "1. Quarterly Consolidated Business Performance" on page 4.

Quarterly Financial Results for the 1st Quarter, Ended June 30, 2022, Kaneka Corporation (4118)

1. Quarterly Consolidated Business Performance ------------------------------------------------------

2. Quarterly Consolidated Financial Statements and Main Notes ---------------------------------

Quarterly Consolidated Balance Sheets ----------------------------------------------------------

Quarterly Consolidated Statements of Income and Comprehensive Income ------------

Notes to the Consolidated Financial Statements -----------------------------------------------

(Notes on the Premise of a Going Concern) -----------------------------------------------------

(Notes in the Event of Significant Changes in the Amount of Shareholders' Equity)

(Changes in Accounting Principles) ----------------------------------------------------------------

Quarterly Financial Results for the 1st Quarter, Ended June 30, 2022, Kaneka Corporation (4118)

Business performance for the first three months (April 1, 2022 to June 30, 2022)

Net sales and operating income by segments for the first three months (April 1, 2022 to June 30, 2022)

Quarterly Financial Results for the 1st Quarter, Ended June 30, 2022, Kaneka Corporation (4118)

The operating performance by business segment was as follows:

This is an excerpt of the original content. To continue reading it, access the original document here.

Kaneka Corporation published this content on 16 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 August 2022 05:31:06 UTC.